ロード中...
Recent Progress on Immunotherapy for Breast Cancer: Tumor Microenvironment, Nanotechnology and More
Immunotherapy is a major emerging treatment for breast cancer (BC). However, not all breast cancer patients derive benefit from immunotherapy. Predictive biomarkers of immunotherapy, such as tumor mutation burden and tumor-infiltrating lymphocytes, are promising to stratify the patients with BC and...
保存先:
| 出版年: | Front Bioeng Biotechnol |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Frontiers Media S.A.
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8207056/ https://ncbi.nlm.nih.gov/pubmed/34150736 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fbioe.2021.680315 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|